ACSM2A

gene product
A-923A4.1, ACSM2, MGC150530
This gene encodes a mitochondrial acyl-coenzyme A synthetase that is specific for medium chain fatty acids. These enzymes catalyze fatty acid activation, the first step of fatty acid metabolism, through the transfer of acyl-CoA. These enzymes also participate in the glycine conjugation pathway in the detoxification of xenobiotics such as benzoate and ibuprofen. Expression levels of this gene in the kidney may be correlated with kidney function. This gene and its paralog ACSM2B (Gene ID: 348158), both present on chromosome 16, likely arose from a chromosomal duplication event. [provided by RefSeq, May 2017]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
83 antibodies from 19 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
Biorbyt
3 antibodies
Invitrogen Antibodies
3 antibodies
Novus Biologicals
3 antibodies
Atlas Antibodies
1 antibody
NovoPro Bioscience Inc.
1 antibody
antibodies-online
27 antibodies
LifeSpan BioSciences, Inc.
19 antibodies
Aviva Systems Biology
2 antibodies
GeneTex
1 antibody
OriGene
1 antibody
Creative Diagnostics
2 antibodies
Boster Biological Technology
1 antibody
MyBioSource
1 antibody
St John's Laboratory
1 antibody
United States Biological
13 antibodies
Abgent
1 antibody
Leading Biology
1 antibody
ProSci
1 antibody